This study formed part of a survey of viral emergence in Pygmies from Cameroon, conducted from 2005 to 2008 (1-3). Informed consent was obtained from adults or parents, in the case of children, before blood sampling. Furthermore, the participants of the study underwent a medical examination and, if necessary, were treated according to local procedures on site or were sent to local medical facilities. The geographic localization, the number of subjects included in each group, their mean age and sex ratio are shown in Fig. 1A .
The presence of antibodies against HCV (anti-HCV) was checked by a third generation enzyme immunoassay (EIA) (Monolisa anti-HCV Plus version 2, Biorad, Marne-La-Coquette, France). A positive result for anti-HCV was defined as a Monolisa ratio of greater than 6 (16).
Out of the 346 available samples tested, only 2 (one Baka and one Bedzan; 0.6%, 95% CI 0.9-1.9%) were anti-HCV-positive. These samples were negative when tested for HCV RNA.
HBV surface antigen (HBsAg) was screened by a third generation EIA (Monolisa AgHBs Plus, Biorad). Of the 524 samples tested, 62 (11.8%; 95% CI 9.2-14.9%) were positive. The prevalence of HBsAg was not statistically different between the three ethnic groups over the same age range. However, in the Baka population, there was a significant association between a decrease in HBsAg and an increase in age, dropping from 23.5% in the ≤ 10 years age group to 6.6% among the > 50 year old population (P < 0.001) ( Table 1 ).
Consequent to their use in a larger epidemiological survey in the same population (1-3), not all samples were available for molecular analyses. A 423-bp fragment of the HBV S gene was amplified as described (18) and sequenced, from 22 HBsAg-positive sera (from 15 Baka, 5
Bakola and 2 Bedzan individuals). After sequence alignment, 17 (77.3%) sequences were seen to belong to the HBV-A3 subgenotype and 5 (22.7%) to the HBV-E genotype. Interestingly, the 15 sequences from Baka individuals were all of the HBV-A3 subgenotype, while there was a co-circulation of HBV-A3 and HBV-E sequences in the Bakola and Bedzam groups, with the 4 HBV-E genotype being predominant among the Bakola population (80%) (Fig. 1B) . The 17 HBV-A3 subgenotype sequences clustered with previously reported HBV-A4 and -A5 subgenotypes (17) , although this observation was not supported by a high bootstrap value,.
This group was designated as the "quasi A3 subgenotype".
The present study confirms the very low rate of infection of the Baka in Cameroon by HCV (8) and extends this conclusion to the Bakola and Bedzan populations. Such a low viral prevalence, especially among elderly pygmies (people aged above 50 years), contrasts with the high rates found among the neighbouring Bantu populations (5, 8, 10, 13, 15) and points to a different route/dynamics of HCV transmission in Cameroon. A hypothesis is that transmission in the past among the Bantu had occurred during mass treatment and vaccination with unsafe material (14) .
The prevalence of HBsAg noted in our study was comparable to that reported previously among the Baka (8, 12) , was similar to that reported among Bantu populations (4, From a molecular point of view, our data confirm the co-circulation of HBV-A3 and HBV-E genotypes in Pygmies living in Cameroon (8) . Interestingly, Baka Pygmies were only infected by the HBV-A3 subgenotype, whereas the HBV-E genotype was predominant in the Bakola population. Despite the relatively small sample size, the different HBV genotypes present in Baka versus Bakola Pygmies raise questions regarding the origin of these viruses.
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The high prevalence of the HBV-A3 subgenotype, and its presence in the three groups of Pygmy, suggests a protracted natural history of this subgenotype in Cameroon, whereas the low prevalence of the HBV-E genotype may indicate it's recent introduction into this area.
These results are in agreement with previous studies that reported a Central African origin for the HBV A3 subgenotype and a West African origin for HBV-E (9). It is also of note that even though Pygmies still frequently hunt, none of the recent HBV isolates are related to HBV genotypes from chimpanzee or gorilla, suggesting the absence of cross-species transmission of this virus. This situation contrasts with that observed for foamy retroviruses in the same populations (2).
In conclusion, our data demonstrate a low prevalence of HCV infection among Pygmies Nucleotide sequence accession numbers. The GenBank accession numbers of the HBV-A3 subgenotype and HBV-E genotype sequences described in this study are HM355550 to HM355571. 
